BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 7656330)

  • 21. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
    Champagne E; Scarpellino L; Lane P; Acha-Orbea H
    Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
    J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of activation markers during tolerance induction by superantigens in T-cell receptor (beta-chain) transgenic mice.
    Perkins DL; Listman JA; Wang Y; Ho SS; Finn PW; Rimm IJ
    Cell Immunol; 1994 Jul; 156(2):310-21. PubMed ID: 8025950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
    Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
    J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CD4+ and CD8+ cell subsets during amplification of natural T cell activity against IgG2ab in Igha mice and during induction of IgG2ab allotype suppression in Igha/b mice.
    Majlessi L; Benaroch P; Denoyelle C; Bordenave G
    J Immunol; 1993 Aug; 151(4):1859-67. PubMed ID: 8102153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo.
    Webb SR; Hutchinson J; Hayden K; Sprent J
    J Immunol; 1994 Jan; 152(2):586-97. PubMed ID: 8283040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
    Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
    J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of an Mls-1a-like superantigen to BALB/c mice by foster-nursing on F1 Mls-1bxa mothers. Sex-influenced onset of clonal deletion.
    Piazzon I; Goldman A; Torello S; Nepomnaschy I; Deroche A; Dran G
    J Immunol; 1994 Aug; 153(4):1553-62. PubMed ID: 7913941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
    Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
    Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD; Saha B; Hodes RJ; Abe R
    J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A superantigen interacts with leishmanial infection in antigen-presenting cells to regulate cytokine commitment of responding CD4 T cells.
    Varanasi V; Mattoo H; Tupperwar NC; Thyagarajan K; Das A; Kumar R; Bal V; Vaidya T; George A; Rath S
    J Infect Dis; 2010 Oct; 202(8):1234-45. PubMed ID: 20831385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Igh-1b-specific CD4+CD8- T cell clones of the Th1 subset selectively suppress the Igh-1b allotype in vivo.
    Bartnes K; Hannestad K
    Eur J Immunol; 1991 Oct; 21(10):2365-71. PubMed ID: 1680695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.